241 related articles for article (PubMed ID: 26371611)
1. Time and Money: The True Costs of Health Care Utilization for Patients Receiving "Free" HIV/Tuberculosis Care and Treatment in Rural KwaZulu-Natal.
Chimbindi N; Bor J; Newell ML; Tanser F; Baltussen R; Hontelez J; de Vlas SJ; Lurie M; Pillay D; Bärnighausen T
J Acquir Immune Defic Syndr; 2015 Oct; 70(2):e52-60. PubMed ID: 26371611
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa.
Naidoo K; Grobler AC; Deghaye N; Reddy T; Gengiah S; Gray A; Abdool Karim S
J Acquir Immune Defic Syndr; 2015 Aug; 69(5):576-84. PubMed ID: 26167618
[TBL] [Abstract][Full Text] [Related]
3. Preventing tuberculosis with community-based care in an HIV-endemic setting: a modelling analysis.
Ross JM; Greene C; Broshkevitch CJ; Dowdy DW; van Heerden A; Heitner J; Rao DW; Roberts DA; Shapiro AE; Zabinsky ZB; Barnabas RV
J Int AIDS Soc; 2024 Jun; 27(6):e26272. PubMed ID: 38861426
[TBL] [Abstract][Full Text] [Related]
4. Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol.
Naidoo K; Gengiah S; Yende-Zuma N; Padayatchi N; Barker P; Nunn A; Subrayen P; Abdool Karim SS
Implement Sci; 2017 Nov; 12(1):129. PubMed ID: 29132380
[TBL] [Abstract][Full Text] [Related]
5. Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa.
Nyasulu PS; Ngasama E; Tamuzi JL; Sigwadhi LN; Ozougwu LU; Nhandara RBC; Ayele BT; Umanah T; Ncayiyana J
PLoS One; 2022; 17(10):e0274549. PubMed ID: 36223365
[TBL] [Abstract][Full Text] [Related]
6. First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status.
Chittamany P; Yamanaka T; Suthepmany S; Sorsavanh T; Siphanthong P; Sebert J; Viney K; Vixaysouk T; Nagai M; Seevisay V; Izumi K; Morishita F; Nishikiori N
PLoS One; 2020; 15(11):e0241862. PubMed ID: 33180777
[TBL] [Abstract][Full Text] [Related]
7. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
Nglazi MD; Bekker LG; Wood R; Kaplan R
BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households.
Kilale AM; Pantoja A; Jani B; Range N; Ngowi BJ; Makasi C; Majaha M; Manga CD; Haule S; Wilfred A; Hilary P; Mahamba V; Nkiligi E; Muhandiki W; Matechi E; Mutayoba B; Nishkiori N; Ershova J
BMC Public Health; 2022 Mar; 22(1):600. PubMed ID: 35351063
[TBL] [Abstract][Full Text] [Related]
9. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.
Zachariah R; Harries AD; Manzi M; Gomani P; Teck R; Phillips M; Firmenich P
PLoS One; 2006 Dec; 1(1):e121. PubMed ID: 17205125
[TBL] [Abstract][Full Text] [Related]
10. Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs.
Nicholas S; Sabapathy K; Ferreyra C; Varaine F; Pujades-Rodríguez M;
J Acquir Immune Defic Syndr; 2011 Aug; 57(4):311-8. PubMed ID: 21423023
[TBL] [Abstract][Full Text] [Related]
11. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
[TBL] [Abstract][Full Text] [Related]
12. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.
Pretorius C; Menzies NA; Chindelevitch L; Cohen T; Cori A; Eaton JW; Fraser C; Gopalappa C; Hallett TB; Salomon JA; Stover J; White RG; Dodd PJ
AIDS; 2014 Jan; 28 Suppl 1():S25-34. PubMed ID: 24468944
[TBL] [Abstract][Full Text] [Related]
13. Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review.
Hudson M; Rutherford GW; Weiser S; Fair E
PLoS One; 2018; 13(4):e0194960. PubMed ID: 29634772
[TBL] [Abstract][Full Text] [Related]
14. A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients' economic outcomes in Eswatini.
Steinert JI; Khan S; Mlambo K; Walsh FJ; Mafara E; Lejeune C; Wong C; Hettema A; Ogbuoji O; Vollmer S; De Neve JW; Mazibuko S; Okello V; Bärnighausen T; Geldsetzer P
Elife; 2020 Aug; 9():. PubMed ID: 32831169
[TBL] [Abstract][Full Text] [Related]
15. Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence.
Currie CS; Floyd K; Williams BG; Dye C
BMC Public Health; 2005 Dec; 5():130. PubMed ID: 16343345
[TBL] [Abstract][Full Text] [Related]
16. Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008-2010.
Webb Mazinyo E; Kim L; Masuku S; Lancaster JL; Odendaal R; Uys M; Podewils LJ; Van der Walt ML
PLoS One; 2016; 11(7):e0159317. PubMed ID: 27442440
[TBL] [Abstract][Full Text] [Related]
17. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa.
Barker C; Dutta A; Klein K
J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21648. PubMed ID: 28770597
[TBL] [Abstract][Full Text] [Related]
18. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
Lawn SD; Myer L; Bekker LG; Wood R
AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441
[TBL] [Abstract][Full Text] [Related]
19. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
